Product Program year 2025 Source: CMS Open Payments

Clinical Trial Product

Device Clinical Trial Product_EP

Open in the dashboard

General payments

$64,586

42 payments

Research payments

$122,647

50 payments

Through program year 2025, $64,586 in general payments and $122,647 in research payments were reported against Clinical Trial Product (Clinical Trial Product_EP).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $59,708 30
2025 Research $1,000 2
2024 Research $121,647 48
2022 General $4,878 12

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $64,586 42 payments
Top recipients General payments · program year 2025
  1. Teresa De Marco Advanced Heart Failure and Transplant Cardiology · San Francisco, CA $7,970 13% · 3 payments
  2. James Heywood Advanced Heart Failure and Transplant Cardiology · La Jolla, CA $7,370 12% · 2 payments
  3. Brian Jaski Advanced Heart Failure and Transplant Cardiology · San Diego, CA $7,270 12% · 2 payments
  4. Suneet Mittal Clinical Cardiac Electrophysiology · Paramus, NJ $6,955 12% · 3 payments
  5. Jeanne Poole Clinical Cardiac Electrophysiology · Seattle, WA $6,575 11% · 2 payments

The top 5 of 22 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $34,895 58% · 17 practitioners
  2. Advanced Heart Failure and Transplant Cardiology Internal Medicine $22,610 38% · 3 practitioners
  3. Cardiovascular Disease Internal Medicine $2,188 4% · 1 practitioner
  4. Nurse Practitioner, Family Nurse Practitioner $16 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $22,676 38% · 4 recipients
  2. Ohio $8,763 15% · 2 recipients
  3. Washington $7,825 13% · 2 recipients
  4. New Jersey $6,955 12% · 1 recipient
  5. Florida $2,219 4% · 3 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

42 general · 50 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record